Status:
COMPLETED
Rheumatoid Arthritis (DMARD) Intervention and UtilizationStudy
Lead Sponsor:
Amgen
Collaborating Sponsors:
Immunex Corporation
Wyeth is now a wholly owned subsidiary of Pfizer
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Brief Summary
The Rheumatoid Arthritis DMARD Intervention and Utilization Study (RADIUS 1) is designed to systematically collect and document use patterns, effectiveness, and safety of DMARD treatments currently us...
Eligibility Criteria
Inclusion
- Fulfillment of the 1987 American Rheumatism Association criteria for RA
- Currently requiring a new DMARD (change or addition)
Exclusion
- Currently enrolled in a clinical trial with treatments or patient visits imposed by a protocol
- Nursing or pregnant women
- Patients with active infection
Key Trial Info
Start Date :
October 1 2001
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2008
Estimated Enrollment :
4968 Patients enrolled
Trial Details
Trial ID
NCT00116714
Start Date
October 1 2001
End Date
October 1 2008
Last Update
May 6 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.